Display options
Cite
Abidi MZ, Coelho-Prabhu N, Hargreaves J, et al. Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature. Case Rep Med. 2014;2014:637492doi: 10.1155/2014/637492.
Abidi, M. Z., Coelho-Prabhu, N., Hargreaves, J., Weiland, T., Van Dyken, I., Tande, A., Tosh, P. K., Walker, R. C., & Cummins, N. W. (2014). Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature. Case reports in medicine, 2014637492. https://doi.org/10.1155/2014/637492
Abidi, Maheen Z, et al. "Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature." Case reports in medicine vol. 2014 (2014): 637492. doi: https://doi.org/10.1155/2014/637492
Abidi MZ, Coelho-Prabhu N, Hargreaves J, Weiland T, Van Dyken I, Tande A, Tosh PK, Walker RC, Cummins NW. Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature. Case Rep Med. 2014;2014:637492. doi: 10.1155/2014/637492. Epub 2014 Apr 27. PMID: 24872818; PMCID: PMC4020554.
Copy Download .nbib Format: NLM
Share it on

Case Rep Med. 2014;2014:637492. doi: 10.1155/2014/637492. Epub 2014 Apr 27.

Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature.

Case reports in medicine

Maheen Z Abidi, Nayantara Coelho-Prabhu, James Hargreaves, Tim Weiland, Irminne Van Dyken, Aaron Tande, Pritish K Tosh, Randall C Walker, Nathan W Cummins

Affiliations

  1. Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  2. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
  3. Altru Medical Center, Grand Forks, ND 58201, USA.
  4. Division of Infectious Diseases, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA.

PMID: 24872818 PMCID: PMC4020554 DOI: 10.1155/2014/637492

Abstract

Mucormycosis is a rare and often fatal invasive fungal infection mostly seen in immune-compromised individuals. A high index of clinical suspicion is necessary, so that effective preemptive therapy can be started, as timely intervention is crucial. In this series we present three cases of invasive mucormycosis in patients with underlying inflammatory bowel disease that had received therapy with immunomodulators prior to the infection. All three had varied clinical manifestations. We also review the literature of invasive mucormycosis in patients with inflammatory bowel disease.

References

  1. J Infect. 2002 Apr;44(3):203-4 - PubMed
  2. Am J Clin Pathol. 1982 Jul;78(1):42-7 - PubMed
  3. Digestion. 2009;80(3):182-4 - PubMed
  4. Haematologica. 2013 Apr;98(4):492-504 - PubMed
  5. Clin Infect Dis. 2008 Aug 1;47(3):364-71 - PubMed
  6. Clin Infect Dis. 2012 Feb;54 Suppl 1:S73-8 - PubMed
  7. Thorac Cardiovasc Surg. 2007 Jun;55(4):257-8 - PubMed
  8. Clin Microbiol Rev. 2005 Jul;18(3):556-69 - PubMed
  9. Clin Microbiol Infect. 1997 Apr;3(2):268-270 - PubMed
  10. Clin Infect Dis. 2009 Jun 15;48(12):1743-51 - PubMed
  11. Blood. 2011 Aug 4;118(5):1216-24 - PubMed
  12. Clin Infect Dis. 2012 Feb;54 Suppl 1:S16-22 - PubMed
  13. Dig Dis Sci. 2007 Sep;52(9):2078-81 - PubMed
  14. Clin Infect Dis. 2008 Aug 15;47(4):503-9 - PubMed
  15. Infect Dis Clin North Am. 2006 Sep;20(3):581-607, vi - PubMed
  16. Antimicrob Agents Chemother. 2005 Feb;49(2):830-2 - PubMed
  17. Case Rep Pulmonol. 2012;2012:120809 - PubMed
  18. Gut. 2006 Mar;55 Suppl 1:i16-35 - PubMed
  19. Arch Intern Med. 1999 Jun 28;159(12):1301-9 - PubMed
  20. Clin Infect Dis. 2012 Feb;54 Suppl 1:S1-4 - PubMed
  21. Antimicrob Agents Chemother. 2008 Apr;52(4):1556-8 - PubMed
  22. MedGenMed. 2005 Sep 21;7(3):7 - PubMed
  23. J Infect Dis. 2005 Apr 15;191(8):1350-60 - PubMed
  24. Med Mycol. 2010 Dec;48(8):1096-8 - PubMed
  25. Clin Infect Dis. 2005 Sep 1;41(5):634-53 - PubMed
  26. Mycopathologia. 2007 Oct;164(4):197-9 - PubMed

Publication Types